Peeters Maxim, Jansen Yanina, Daemen Jean H T, van Roozendaal Lori M, De Leyn Paul, Hulsewé Karel W E, Vissers Yvonne L J, de Loos Erik R
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Division of Thoracic Surgery, Department of General Surgery, Zuyderland Medical Center, Heerlen, The Netherlands.
Transl Lung Cancer Res. 2024 Mar 29;13(3):612-622. doi: 10.21037/tlcr-23-807. Epub 2024 Mar 27.
To identify intersegmental planes (ISPs) in video/robot-assisted thoracoscopic segmentectomies, indocyanine green (ICG) is commonly used. The aim of this systematic review is to evaluate the efficacy of intravenous ICG in the identification of ISP.
A systematic search was performed. Studies evaluating patients who underwent a video/robot-assisted thoracoscopic segmentectomy using intravenous ICG were included. The primary outcome measure was the frequency and percentage of patients in whom the ISP was adequately visualized. Secondary outcomes encompassed the ICG dose, time to visualization, time to maximum ICG visualization, time to disappearance of ICG effect and adverse reactions to ICG.
Eighteen studies were included for systematic review, enrolling a total of 1,090 patients. Irrespective of the injected dose, intravenous ICG identified the ISP in 94% of the cases (range, 30-100%). Overall, there was a considerable amount of heterogeneity regarding the injected dose of ICG (range, 5-25 mg or 0.05-0.5 mg/kg). The mean time before first effect of ICG was visible ranged from 10 to 40 seconds. The mean total time of ICG visibility ranged from 90 to 140 seconds after a bolus injection and was 170 seconds after continuous infusion. No adverse reactions were reported.
After administration of intravenous ICG, visualization of the ISP is successful in up to 94% of cases, even after administration of a low dose (0.05 mg/kg) of ICG. The use of intravenous ICG is safe with no reported adverse effects in the immediate peri-operative period.
在视频/机器人辅助胸腔镜肺段切除术中,为了识别节段间平面(ISP),吲哚菁绿(ICG)被广泛使用。本系统评价的目的是评估静脉注射ICG在识别ISP方面的有效性。
进行了系统检索。纳入评估使用静脉注射ICG进行视频/机器人辅助胸腔镜肺段切除术患者的研究。主要结局指标是ISP得到充分显影的患者的频率和百分比。次要结局包括ICG剂量、显影时间、ICG最大显影时间、ICG效果消失时间以及对ICG的不良反应。
纳入18项研究进行系统评价,共纳入1090例患者。无论注射剂量如何,静脉注射ICG在94%的病例中识别出了ISP(范围为30%-100%)。总体而言,关于ICG的注射剂量存在相当大的异质性(范围为5-25mg或0.05-0.5mg/kg)。ICG首次显效前的平均时间为10至40秒。推注后ICG可见的平均总时间为90至140秒,持续输注后为170秒。未报告不良反应。
静脉注射ICG后,即使给予低剂量(0.05mg/kg)的ICG,在高达94%的病例中也能成功显影ISP。静脉注射ICG的使用是安全的,在围手术期即刻未报告不良反应。